Adherium Ltd. | Cash Flow

Fiscal year is July-June. All values AUD Thousands.
2016
2017
2018
Net Income before Extraordinaries
7,885.00
12,810.00
-
Depreciation, Depletion & Amortization
164.00
270.00
-
Other Funds
725.00
404.00
-
Funds from Operations
6,996.00
12,136.00
-
Changes in Working Capital
917.00
555.00
-
Net Operating Cash Flow
7,913.00
11,581.00
-
Capital Expenditures
440.00
564.00
-
Net Investing Cash Flow
440.00
564.00
-
Issuance/Reduction of Debt, Net
43.00
-
-
Net Financing Cash Flow
31,912.00
7,558.00
-
Net Change in Cash
23,743.00
4,432.00
-
Free Cash Flow
8,210.00
11,943.00
-
Change in Capital Stock
31,955.00
7,558.00
-
Exchange Rate Effect
184.00
155.00
-

About Adherium

View Profile
Address
204 Quay Street
Auckland AU 1010
New Zealand
Employees -
Website http://www.adherium.com
Updated 07/08/2019
Adherium Ltd. engages in the development, manufacture, and supply of digital health technologies which addresses suboptimal medicine use in chronic disease. Its product platform Smartinhaler, comprises of medical devices which monitors inhaler actuation and provides audio and visual medication reminders; and SmartinhalerLive software, which integrates data from the Smartinhaler into a usable form. The company was founded by Garth Sutherland on April 7, 2015 and is headquartered in Auckland, New Zealand.